Published in Pharma Law Weekly, December 26th, 2006
This trend article about Emory University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A report, "Impaired memory CD8 T cell development in the absence of methyl-CpG-binding domain protein 2," is newly published data in The Journal of Immunology. "Intracellular differentiation events that determine which cells develop into memory CD8 T cells are currently incompletely understood. Methyl-CpG-binding domain protein 2 (MBD2) is a transcriptional repressor that binds to methylated DNA and mediates the biological consequences of epigenetic gene...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-12-26)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.